US-CONGRESS BILLS-119hr10048ih: Truth in Labeling Act of 2026
The Truth in Labeling Act of 2026 (H.R. 10048) has been introduced in the U.S. House of Representatives, proposing new labeling requirements for dietary supplements, including mandatory product listing with the FDA and stricter rules for structure/function claims.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on August 12, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Dietary supplement brands, contract manufacturers, private-label sellers, and ingredient suppliers in the U.S. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified; bill is in early legislative stage.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The bill introduces mandatory product listing for dietary supplements with the FDA, and requires that structure/function claims be substantiated and not misleading, with potential for increased FDA enforcement.
Who it affects
Dietary supplement brands, contract manufacturers, private-label sellers, and ingredient suppliers in the U.S.
What you must do
Monitor the bill's progress and prepare for potential new compliance requirements, including product listing and claim substantiation.
Deadline
Not specified; bill is in early legislative stage.
Source: https://www.govinfo.gov/app/details/BILLS-119hr10048ih
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Dietary-Supplement Labeling (FDA)
- IL HB0001: HEMP CANNABINOIDS-MINORS
- Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
- Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 066
- Warning Letters | FDA
- Texas Updates Food Labeling Law: 44 Ingredients Require Warning Labels - CIRS Group